FI880027A0 - Antibakteriellt lyofiliserat preparat. - Google Patents

Antibakteriellt lyofiliserat preparat.

Info

Publication number
FI880027A0
FI880027A0 FI880027A FI880027A FI880027A0 FI 880027 A0 FI880027 A0 FI 880027A0 FI 880027 A FI880027 A FI 880027A FI 880027 A FI880027 A FI 880027A FI 880027 A0 FI880027 A0 FI 880027A0
Authority
FI
Finland
Prior art keywords
antibacterial
aspoxicillin
preparation
lyophilized preparation
lyophilised preparations
Prior art date
Application number
FI880027A
Other languages
English (en)
Other versions
FI89454B (fi
FI880027A (fi
FI89454C (fi
Inventor
Keiichi Kohno
Hiroshi Miura
Yoshiyuki Hirakawa
Toshiyuki Ueki
Seiichi Morikuni
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of FI880027A0 publication Critical patent/FI880027A0/fi
Publication of FI880027A publication Critical patent/FI880027A/fi
Publication of FI89454B publication Critical patent/FI89454B/fi
Application granted granted Critical
Publication of FI89454C publication Critical patent/FI89454C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
FI880027A 1987-01-14 1988-01-06 Foerfarande foer framstaellning av ett lyofiliserat antibakteriellt preparat FI89454C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP686887 1987-01-14
JP62006868A JPS63174927A (ja) 1987-01-14 1987-01-14 抗菌性凍結乾燥製剤

Publications (4)

Publication Number Publication Date
FI880027A0 true FI880027A0 (fi) 1988-01-06
FI880027A FI880027A (fi) 1988-07-15
FI89454B FI89454B (fi) 1993-06-30
FI89454C FI89454C (fi) 1993-10-11

Family

ID=11650214

Family Applications (1)

Application Number Title Priority Date Filing Date
FI880027A FI89454C (fi) 1987-01-14 1988-01-06 Foerfarande foer framstaellning av ett lyofiliserat antibakteriellt preparat

Country Status (18)

Country Link
US (1) US4966899A (fi)
EP (1) EP0278243B1 (fi)
JP (1) JPS63174927A (fi)
KR (1) KR930001830B1 (fi)
CN (1) CN1024754C (fi)
AT (1) ATE61222T1 (fi)
AU (1) AU597463B2 (fi)
CA (1) CA1308358C (fi)
DE (1) DE3861866D1 (fi)
DK (1) DK15088A (fi)
ES (1) ES2031930T3 (fi)
FI (1) FI89454C (fi)
GR (1) GR3001565T3 (fi)
HK (1) HK63592A (fi)
HU (1) HU197985B (fi)
IE (1) IE60049B1 (fi)
IL (1) IL85031A (fi)
SG (1) SG60292G (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE100210T1 (de) * 1988-11-01 1994-01-15 Sanol Arznei Schwarz Gmbh Lyophilisiertes mdm enthaltende zusammensetzung und verfahren zu deren herstellung.
DE69528166T2 (de) * 1994-05-02 2003-04-30 Shionogi & Co Kristalline pyrrolidylthiocarbapenem derivate, lyophilisierste präparationen dieser kristalle und verfahren zu deren herstellung
US8252228B1 (en) * 2008-10-13 2012-08-28 Abbott Cardiovascular Systems Inc. Methods for sterilizing carriers for treatment of a kidney
CN102372727A (zh) * 2010-08-10 2012-03-14 海南美好西林生物制药有限公司 一种阿扑西林钠的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3733404A (en) * 1970-09-04 1973-05-15 Squibb & Sons Inc Antibacterial composition containing alpha-aminobenzyl penicillins
US4053609A (en) * 1975-09-12 1977-10-11 Tanabe Seiyaku Co., Ltd. Penicillins and processes for preparing the same
DE2623835C2 (de) * 1976-05-28 1978-03-02 C.H. Boehringer Sohn, 6507 Ingelheim Verfahren zur Herstellung von Natriumampicillin
GB1539510A (en) * 1976-08-23 1979-01-31 Beecham Group Ltd Injectable compositions
JPS5640686A (en) * 1979-09-11 1981-04-16 Tanabe Seiyaku Co Ltd Purification of penicillin derivative
CA1242699A (en) * 1985-02-01 1988-10-04 Bristol-Myers Company Cefbuperazone and derivatives thereof

Also Published As

Publication number Publication date
IE880049L (en) 1988-07-14
DK15088A (da) 1988-07-15
SG60292G (en) 1992-09-04
EP0278243B1 (en) 1991-03-06
KR930001830B1 (ko) 1993-03-15
FI89454B (fi) 1993-06-30
CN1024754C (zh) 1994-06-01
HK63592A (en) 1992-08-28
GR3001565T3 (en) 1992-11-23
IE60049B1 (en) 1994-05-18
DE3861866D1 (de) 1991-04-11
ATE61222T1 (de) 1991-03-15
IL85031A (en) 1992-07-15
KR880008812A (ko) 1988-09-13
HUT46212A (en) 1988-10-28
JPS63174927A (ja) 1988-07-19
JPH053847B2 (fi) 1993-01-18
FI880027A (fi) 1988-07-15
EP0278243A1 (en) 1988-08-17
HU197985B (en) 1989-07-28
CN1034131A (zh) 1989-07-26
ES2031930T3 (es) 1993-01-01
AU597463B2 (en) 1990-05-31
FI89454C (fi) 1993-10-11
US4966899A (en) 1990-10-30
DK15088D0 (da) 1988-01-13
CA1308358C (en) 1992-10-06
AU1022688A (en) 1988-07-21

Similar Documents

Publication Publication Date Title
DE69434963D1 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
DE3688114D1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
ZA885192B (en) Pharmaceutical preparations
DK642587A (da) Insulinpraeparat
PT88985A (pt) Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
YU126186A (en) Process for making water gelating solutions of arylpropionic acid derivatives, which can be respirated through skin
BR9401199A (pt) Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento.
NO307326B1 (no) Lipofile, oligosakkaride antibiotikasaltpreparater
ES2102393T3 (es) Complejos de acido quinolona carboxilico--ion metalico--acido.
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
FI880027A0 (fi) Antibakteriellt lyofiliserat preparat.
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
KR910005886A (ko) 안정화 백혈구 인터페론
EP0209843A3 (en) Benzylpiperazine compound, preparation thereof, pharmaceutical composition, and use
MX9302711A (es) Preparacion de base.
GR3001793T3 (en) Polyprenyl alcohol-containing injections and use thereof
ATE2746T1 (de) Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
IT8620703A0 (it) Derivati dell'acido 4-fenil 4-osso 2-butenoico, loro procedimento di preparazione e loro impiego come prodotti medicinali.
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
EP0056681A3 (en) Levonantradol and n-methyllevonantradol formulations
NO301805B1 (no) Fremgangsmåte for fremstilling av et stabilt, galenisk, vandig preparat av erytropoietin
EP0189587A3 (en) Method of sterilizing recombinant microorganism
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
IT1238210B (it) Esteri del cefamandolo nafato, procedimento per la loro preparazione erelative composizioni farmaceutiche.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: TANABE SEIYAKU CO., . LTD.